Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 160.00
-4.20 (-2.56%)
At close: Jul 27, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 1.78 billion as of July 28, 2026. Its market cap has increased by 156.00% in one year.
Market Cap
1.78B
Enterprise Value
1.86B
Revenue
898.18M
Ranking
n/a
PE Ratio
17.72
Stock Price
160.00
ChartMarket Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 1.78B, an increase of 92.89%. That is a compound annual growth rate of 74.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 1.78B | 82.13% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gennex Laboratories | 2.21B |
| Sat Kartar Life | 2.15B |
| Coral Laboratories | 2.08B |
| Kerala Ayurveda | 1.97B |
| Oxygenta Pharmaceutical | 1.88B |
| Sanjivani Paranteral | 1.83B |
| Bio Medica Laboratories | 1.74B |
| Speciality Medicines | 1.63B |